```json
{
"content": [
{
"type": "paragraph",
"content": "The Microwave Ablation Devices market segmentation by Application reflects the therapeutic demand for treating cancerous and non-cancerous tissue. Primary applications include liver tumor ablation, which dominates the segment due to the high incidence of hepatocellular carcinoma and the superiority of microwave technology in thermal precision compared to radiofrequency ablation. Liver tumors account for approximately 45% of the Microwave Ablation Devices market size, driven by minimally invasive treatment preferences. Lung tumor ablation constitutes 30%, fueled by rising lung cancer prevalence and the ability of microwave devices to overcome the "heat sink" effect in pulmonary tissue. Other applications, such as kidney, bone, and thyroid tumor ablation, collectively represent 25%, with niche but growing adoption as clinical protocols expand. This segmentation underscores the market’s dependency on oncology trends and procedural advancements."
},
{
"type": "paragraph",
"content": "Microwave Ablation Devices segmentation by Type is critical to understanding technological differentiation. The Single-Pole Antenna segment leads with 60% market share, favored for its simplicity and cost-effectiveness in treating smaller lesions. These devices are widely adopted in hospitals for routine ablation procedures. The Multi-Pole Antenna segment holds 35%, driven by its capacity to address larger tumors through multi-directional energy delivery, though at a higher cost. Emerging Rotational Antenna technologies, accounting for 5%, are gaining traction for their ability to create uniform ablation zones in complex anatomical structures. This taxonomy highlights the balance between affordability and advanced functionality shaping the market."
}
],
"chartData": {
"segments": [
{ "name": "Liver Tumor Ablation", "value": 45 },
{ "name": "Lung Tumor Ablation", "value": 30 },
{ "name": "Other Applications", "value": 25 }
]
}
}
```
